Johnson & Johnson Enters Competitive US Robotic Surgery Market with FDA Approval
Johnson & Johnson has secured US regulatory approval for its Ottava robotic surgery system, marking the company's entry into the competitive soft-tissue robotic surgery market currently dominated by Intuitive Surgical's da Vinci platform.